OUTCOMES OF MYELOFIBROSIS PATIENTS UNDERGOING ALLOGENEIC STEM CELL TRANSPLANTATION WITH TACROLIMUS/METHOTREXATE/RUXOLITINIB AS GRAFT-VERSUS-HOST DISEASE PROPHYLAXIS

EHA Library, Sandro Pino-Ascencio, 4208817

ALLOGENEIC STEM CELL TRANSPLANTATION FOR ADVANCED CUTANEOUS T-CELL LYMPHOMA: EXPERIENCE WITH POST-TRANSPLANT CYCLOPHOSPHAMIDE-BASED GVHD PROPHYLAXIS

EHA Library, Seda Cakmak, 4208818

YOUNG PATIENTS WITH STANDARD-RISK MULTIPLE MYELOMA UNDERGOING AUTOLOGOUS STEM CELL TRANSPLANTATION ARE EXPECTED TO ACHIEVE FUNCTIONAL CURE：A REAL-WORLD MULTICENTER ANALYSIS

EHA Library, Li Bao, 4208819

A MULTICENTER CLINICAL STUDY COMPARING HETROMBOPAG AND ELTROMBOPAG FOR PLATELET ENGRAFTMENT AFTER AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION

EHA Library, Aoxue Tan, 4208820

IMPROVED OUTCOMES WITH YOUNGER RELATED HAPLOIDENTICAL DONORS IN PEDIATRIC AML UNDERGOING HAPLO-HSCT

EHA Library, Qingwei Wang, 4208821

HAPLOIDENTICAL TRANSPLANTATION WITH UNRELATED CORD BLOOD SUPPORT (SZ-19-TM PROTOCOL) IMPROVES OUTCOMES IN PEDIATRIC TRANSFUSION-DEPENDENT THALASSEMIA: A LARGE-SCALE RETROSPECTIVE COHORT STUDY

EHA Library, Ruihao Zheng, 4208822

IMPACT OF AGE ON OUTCOME OF VENETOCLAX-BASED CONDITIONING REGIMEN FOR OLDER PATIENTS WITH AML/MDS FOLLOWING ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION

EHA Library, Panpan Zhu, 4208823

MONOCYTE SUBSETS AND MONOCYTE-RELATED CYTOKINES AS POTENTIAL BIOMARKERS IN CHRONIC GRAFT-VERSUS-HOST DISEASE

EHA Library, Antonija Babić, 4208824

DOES THE AGE-ADJUSTED HCT-CI RETAIN PROGNOSTIC SIGNIFICANCE IN HAPLOIDENTICAL TRANSPLANTATION WITH PTCY?

EHA Library, Hakan Goker, 4208825

UMBILICAL CORD-DERIVED MESENCHYMAL STEM CELLS: ELEVATING EARLY EFFICACY IN GASTROINTESTINAL ACUTE GRAFT-VERSUS-HOST DISEASE

EHA Library, Fang Zhou, 4208826

PSYCHIATRIC STATUS IN CHRONIC GRAFT-VERSUS-HOST DISEASE: A REAL-WORLD DATA.

EHA Library, Jan Puchowski, 4208827

ABSOLUTE AND RELATIVE CD34+ COUNTS AS PREDICTORS OF MOBILIZATION SUCCESS: EXPERIENCE FROM A BRAZILIAN ONCOLOGY CENTER

EHA Library, Marcos Henrique Fogale Piccoli Silva, 4208828

EFFECTS OF TWO ANTITHYMOCYTE GLOBULIN CONDITIONING REGIMENS ON IMMUNE RECONSTITUTION AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION

EHA Library, Hui Wang, 4208829

AI BASED FLT3-ITD SENSITIVITY PREDICTION AND ITS CORRELATION WITH CLINICAL OUTCOMES IN FLT3-ITD AML PATIENTS RECEIVED ALLOGENEIC HCT +/- FLT3 INHIBITOR MAINTENANCE

EHA Library, Seda Cakmak, 4208830

THE CRL4‑DCAF13 UBIQUITIN E3 LIGASE MAINTAINS RIBOSOME BIOGENESIS AND PROTEIN TRANSLATION IN HEMATOPOIETIC STEM CELLS BY STABILIZING RRS1 THROUGH K27-LINKED NON-DEGRADATIVE UBIQUITINATION.

EHA Library, Mengke Li, 4208831

LEUKEMIC STEM CELLS ORCHESTRATE TGFΒ-DEPENDENT BONE MARROW NICHE REMODELING IN AML XENOGRAFT MODELS

EHA Library, Karin Prummel, 4208832

MONOCYTE AND LYMPHOID LINEAGES BIFURCATE FROM COMMON PRECURSORS DISTINCT FROM NEUTROPHIL LINEAGE DURING HEMATOPOIESIS

EHA Library, Yongjian Yue, 4208833

INFLAMED BONE MARROW STROMAL NICHES DRIVE A HIGH‑ENTROPY INFLAMMATORY‑STEMNESS STATE AND HEMATOPOIETIC STEM CELL DYSFUNCTION IN SICKLE CELL DISEASE

EHA Library, Nadia Carlesso, 4208834

IMPAIRED INTERFERON RESPONSE IN BRAFV600E MYELOID PROGENITORS OF LANGERHANS CELL HISTIOCYTOSIS

EHA Library, Maki Sakuma, 4208835

CHROMATIN ACCESSIBILITY ENCODES LINEAGE PLASTICITY IN FIRST-TRIMESTER FETAL HEMATOPOIETIC STEM AND PROGENITOR CELLS

EHA Library, Sara Palo, 4208836

QUIESCENT FETAL, NEONATAL, AND ADULT HUMAN HEMATOPOIETIC STEM CELLS ARE SELECTIVELY MAINTAINED IN FLT3-LIGAND CULTURES

EHA Library, Margarita MacAldaz, 4208837

ALTERED GLUTAMINE METABOLISM IMPAIRS THE HAEMATOPOIETIC STEM CELL RESPONSE TO INFECTION

EHA Library, Charlotte Hellmich, 4208838

MULTIMODAL OMICS IDENTIFY AN AGE RESILIENT MULTIPOTENT PROGENITOR POPULATION IN THE HEMATOPOIETIC SYSTEM

EHA Library, Mari Carmen Romero-Mulero, 4208839

CHARACTERIZATION OF THE BONE MARROW NICHE INTERACTOME OF CHEMORESISTANT ACUTE MYELOID LEUKEMIA

EHA Library, Maria Pereira, 4208840

ABNORMALITIES IN THE BONE MARROW NICHE ARE SUSTAINED AFTER ALLOGENEIC STEM CELL TRANSPLANTATION, SUPPORTING CONTINUED LEUKEMIC DYNAMICS AND RELAPSE OF ACUTE MYELOID LEUKEMIA

EHA Library, Shlomit Yehudai-Reshef, 4208841

LEVERAGING THE INTESTINAL MICROBIOTA TO IMPROVE HSC ENGRAFTMENT

EHA Library, Christopher Peek, 4208842

CLONAL EVOLUTION OF RAS-MAPK MUTATIONS IN HISTIOCYTIC NEOPLASMS REVEALS DISTINCT TRAJECTORIES OF ABERRANT MYELOPOIESIS IN CHILDREN VERSUS ADULTS

EHA Library, Antonia Cuff, 4208843

WNT10B REGULATES THE HEMATOPOIETIC RESPONSE TO ACUTE AND CHRONIC STRESS

EHA Library, Magdalena Havlova, 4208844

DEVELOPMENT OF A TRACTABLE EX VIVO MODEL OF HAEMATOPOIESIS ENABLES CRISPR SCREENING OF LINEAGE REGULATORS

EHA Library, Elizabeth Brown, 4208845

SKP2-INHIBITION IN HUMAN HSPCS: A NEW PROMISING STRATEGY TO ENHANCE HSC MAINTENANCE AND STRESS TOLERANCE DURING IN-VITRO MANIPULATION

EHA Library, Federica Di Biase, 4208846

DIVERGENT EFFECTS OF TET2- AND DNMT3A-MUTANT CLONAL HEMATOPOIESIS ON BREAST CANCER PROGRESSION UPON AGING

EHA Library, Nagihan Gizay Gönüllü, 4208847

BONE MARROW MESENCHYMAL CELLS UNDERGO INFLAMMATORY MYOFIBROBLAST DIFFERENTIATION UPON ALLOGENEIC HSCT CORRELATING WITH AN ALTERED SUPPORT OF HEMATOPOIESIS

EHA Library, Sara Garaali, 4208848

DECODING BLOOD FORMATION: LINKING CODON USAGE, TRANSFER RNA EXPRESSION AND CELL IDENTITY IN HEMATOPOIESIS

EHA Library, Marius Külp, 4208849

UNCOVERING NEW ROLES FOR H/ACA SNORNPS IN MYC-DRIVEN ONCOGENIC STRESS AND HEMATOPOIESIS

EHA Library, Silvia Tucciarone, 4208850

IRON DEFICIENCY IS ASSOCIATED WITH REDUCED TRANSFERRIN RECEPTOR 2 EXPRESSION IN EARLY HEMATOPOIETIC PROGENITORS

EHA Library, João Vitor Facco, 4208851

SCRNA-SEQ ANALYSIS WORKFLOW TO CHARACTERIZE WNT-MODULATED MESODERM AND HEMATOPOIETIC TRAJECTORIES IN HUMAN GASTRULOIDS

EHA Library, Elin Hilpold-Berntsson, 4208852

THE EFFECT OF STATIN THERAPY AND SMALL DENSE LIPOPROTEINS ON CLONAL HAEMATOPOIESIS OF INDETERMINATE POTENTIAL: A TWO SAMPLE MENDELIAN RANDOMISATION STUDY.

EHA Library, Ellen Nuttall Musson, 4208853

A STANDARDIZED IN VITRO BONE NICHE MODEL FOR QUANTITATIVE ANALYSIS OF OSTEOCLAST-MEDIATED MICROENVIRONMENT REMODELING RELEVANT TO HEMATOLOGIC MALIGNANCIES

EHA Library, Min Wu, 4208854

FLT3 INHIBITION SYNERGIZES WITH DNA DAMAGING AGENTS TO ELIMINATE HEMATOPOIETIC STEM AND PROGENITOR CELLS BY SUPPRESSING DNA REPAIR PATHWAYS

EHA Library, Samuel Taylor, 4208855

P-TERT RELATED ADAPTIVE SOMATIC HEMATOPOIETIC MOSAICISM IN PATIENTS WITH TELOMERE BIOLOGY DISORDERS

EHA Library, Madeline Franke, 4208856

PRECLINICAL CHARACTERIZATION OF EVX-04, AN AI-DESIGNED OFF-THE-SHELF CANCER VACCINE TARGETING ENDOGENOUS RETROVIRAL ANTIGENS IN ACUTE MYELOID LEUKEMIA

EHA Library, Søren Vester Kofoed, 4208857

SELECTIVE PRESERVATION OF FYN SIGNALING BY PONATINIB ENHANCES CAR-T CELL PERSISTENCE AND FUNCTIONAL DURABILITY IN B-ALL

EHA Library, Xin Li, 4208858

CO-RECEPTOR ATTENUATION DEFINES A CONVERGENT TRANSCRIPTIONAL STATE OF LONG-TERM PERSISTING CAR-T CELLS DRIVEN BY INTERMITTENT ANTIGEN STIMULATION

EHA Library, Neel Nabar, 4208859

LONG-TERM SAFETY OF CAR T-CELL THERAPY WITH LISOCABTAGENE MARALEUCEL AND IDECABTAGENE VICLEUCEL: ANALYSIS OF SECOND PRIMARY MALIGNANCY (SPM) AND VECTOR-ASSOCIATED OUTCOMES

EHA Library, Matthew Lunning, 4208860

CD1C-RESTRICTED TCR COMBINED WITH CD38-CCR ENABLES POTENT DUAL-TARGETING IMMUNOTHERAPY IN ACUTE LEUKEMIA

EHA Library, Ivan Civettini, 4208861

AN IN VIVO EPIGENOME EDITING PLATFORM FOR Β-HEMOGLOBINOPATHIES USING ADENOVIRAL VECTORS

EHA Library, Kiriaki Paschoudi, 4208862

CORD BLOOD-DERIVED NK CELLS ENGINEERED WITH  A NOVEL HIGH-AFFINITY CAR RECOGNIZING CLL-1 EXHIBIT SIGNIFICANT ANTI-LEUKEMIA EFFECTS IN VIVO

EHA Library, Makiko Suga, 4208863

PRE-INFUSION IMMUNE SIGNATURES PREDICT SEVERE CYTOPENIA AFTER CAR T-CELL THERAPY: HIGH-DIMENSIONAL LONGITUDINAL PROFILING IN B-CELL MALIGNANCIES

EHA Library, Julian Liebaert, 4208864

TARGETING TNFΑ AND IFNG REVERSES CAR-T SECRETOME–INDUCED HUMAN HEMATOPOIETIC STEM CELL IMPAIRMENT

EHA Library, Michael Milyavsky, 4208865

GAMMA DELTA T‑CELL THERAPY NAKU OUTPERFORMS AND ENHANCES AZA/VEN TREATMENT IN PATIENT-DERIVED EX VIVO AML MODELS

EHA Library, Mika Kontro, 4208866

ADJUSTABLE TUNING OF CHIMERIC PROTEIN-EXPRESSING T CELLS WITH BSABS TO AUGMENT T-CELL REDIRECTION THERAPY FOR HEMATOLOGICAL MALIGNANCIES.

EHA Library, Junichi Kato, 4208867

DUAL-INPUT LOGIC-GATED CAR NK CIRCUITS HARNESSING IMMUNE SYNAPSE PROTEASE ACTIVITY FOR TUMOR CONFINED MULTI ANTIGEN ENGAGER CASCADES

EHA Library, Didem Cakirsoy Akyoney, 4208868

BIOLOGICAL PROPERTIES AND CLONALITY OF ENGINEERED HEMATOPOIETIC STEM/PROGENITOR CELLS PERSISTING LONG-TERM AFTER GENE THERAPY

EHA Library, Serena Scala, 4208869

INCORPORATING IN VITRO TRANSCRIPTION MRNA TO PROLONG THE HALF-LIFE OF BISPECIFIC ANTIBODY

EHA Library, Yu Yang, 4208870

SCREENING AND VALIDATION OF TCR–PEPTIDE INTERACTIONS USING INTEGRATED BULK AND SINGLE‑CELL IMMUNE RECEPTOR SEQUENCING

EHA Library, Alex Chenchik, 4208871

FROM BENCH TO BODY: STABLE IN VIVO CAR T-CELL ENGINEERING WITH A T CELL–TROPIC AAV–TRANSPOSON PLATFORM

EHA Library, Mobina Ostadiasrami, 4208872

EARLY IGFBP6 DOWNREGULATION AND ROCK2 ACTIVATION IDENTIFY PATIENTS AT RISK OF ICANS AFTER CD19 CAR-T THERAPY: A REAL-WORLD MOLECULAR MONITORING STUDY

EHA Library, Sara Galimberti, 4208873

CD4/CD8 BALANCE IN CIRCULATING CAR T-CELLS SHOWS BIPHASIC PROGNOSTIC IMPACT ON OVERALL SURVIVAL IN LARGE B-CELL LYMPHOMAS

EHA Library, Ludovic Gabellier, 4208874

A TOOLBOX TO VISUALIZE AND QUANTIFY CHIMERIC ANTIGEN RECEPTORS USING SUPERRESOLUTION MICROSCOPY

EHA Library, Thomas Nerreter, 4208875

SINGLE-CELL PROFILING REVEALS DIFFERENTIAL ACTIVATION OF EX VIVO EXPANDED NATURAL KILLER CELLS ACROSS PEDIATRIC LEUKEMIA SUBTYPES

EHA Library, Tiina Tuononen, 4208876

CAR-T CELL THERAPY FOR THE TREATMENT OF A HIGH-RISK PEDIATRIC AMKL: PRECLINICAL RESULTS

EHA Library, Marta Tassoni, 4208877

EXPLORING THE THERAPEUTIC POTENTIAL OF TCR GENE THERAPY WITH ARGINASE 1-TARGETED METABOLIC INTERVENTION IN PRECLINICAL TUMOR MODEL

EHA Library, Anita Kansy, 4208878

ALLOGENEIC BCMA‑TARGETED CAR‑INKT CELLS WITH PD‑1 DISRUPTION EXHIBIT ENHANCED ANTITUMOR POTENCY IN A MULTIPLE MYELOMA PRECLINICAL MODEL

EHA Library, Hua Zhang, 4208879

EFFICACY AND SAFETY OF COMMERCIAL CD19 CAR-T (INATICABTAGENE AUTOLEUCEL) IN RELAPSED/REFRACTORY EXTRAMEDULLARY B-ALL: A LARGE MULTICENTER REAL-WORLD STUDY

EHA Library, Suning Chen, 4208881

CTD402 ALLOGENEIC ANTI-CD7 CAR T-CELL THERAPY IS SAFE AND EFFECTIVE IN ADOLESCENT/PEDIATRIC PATIENTS (PTS) WITH RELAPSED/REFRACTORY (R/R) T-ALL/LBL

EHA Library, Xian Zhang, 4208882

RISTOGLOGENE AUTOGETEMCEL TREATMENT RESTORED RED BLOOD CELL HEALTH AND FUNCTION IN PATIENTS WITH SICKLE CELL DISEASE, WITH SICKLING AND RHEOLOGY PARAMETERS COMPARABLE TO SICKLE CELL TRAIT

EHA Library, Priya S. Chockalingam, 4208883

LONG-TERM FOLLOW-UP CONFIRMS DURABLE CLINICAL BENEFITS OF EXAGAMGLOGENE AUTOTEMCEL IN TRANSFUSION-DEPENDENT B-THALASSEMIA: FINAL RESULTS OF THE CLIMB THAL-111 STUDY

EHA Library, Roland Meisel, 4208884

SAFETY AND EFFICACY OF HCD1A-CAR T (OC-1) THERAPY, IN PATIENTS WITH RELAPSED/REFRACTORY (R/R) T-CELL ACUTE LYMPHOBLASTIC LEUKAEMIA/LYMPHOMA (T-ALL/LL): A PRE-SPECIFIED INTERIM ANALYSIS.

EHA Library, Nuria Martinez-Cibrian, 4208885

PD-1AB21-EXPRESSING, ANTI-CD19 CAR T CELLS FOR PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA: AN OPEN-LABEL, SINGLE-ARM, PHASE 1 STUDY

EHA Library, Bo Peng, 4208886

SECONDARY MALIGNANCIES AFTER CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELL THERAPY: A REPORT FROM THE EBMT REGISTRY ON 509 CASES.

EHA Library, Annalisa Ruggeri, 4208888

PAIRED SINGLE-CELL ANALYSIS OF STARTING MATERIAL AND CAR T PRODUCT IDENTIFIES CD8+ TEMRA SENESCENCE PROGRAMS LINKED TO CLINICAL RESPONSE IN DLBCL

EHA Library, Yue Chun, 4208889

SEVERE DELAYED NON-ICANS NEUROTOXICITY AFTER BCMA-DIRECTED CAR-T CELLS IN MULTIPLE MYELOMA: REAL-WORLD OUTCOMES AND IMPLICATIONS FOR STRUCTURED NEUROLOGY–ONCOLOGY CARE

EHA Library, Tim Richardson, 4208891

EFFICACY AND SAFETY OF CD19 CAR-T INATICABTAGENE AUTOLEUCEL IN OLDER ADULTS WITH B-ALL IN FIRST COMPLETE REMISSION: A MULTICENTER REAL-WORLD STUDY FROM CHINA

EHA Library, Jin WANG, 4208892

MAINTENANCE THERAPY WITH PD-1 INHIBITOR AND SELINEXOR FOLLOWING CD19/CD22 BISPECIFIC CAR-T CELL THERAPY IN RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA: A RETROSPECTIVE ANALYSIS

EHA Library, Liang Wang, 4208893

THE SUCCESS OF CAR T-CELL THERAPY IS DETERMINED BY PRE-INFUSION DISEASE CONTROL AND POST-INFUSION MRD CLEARANCE MEASURED BY CTDNA IN PATIENTS WITH B-CELL LYMPHOMA

EHA Library, Tim Versteegen, 4208894

TAZEMETOSTAT-MEDIATED IMMUNE REMODELING IN B-CELL LYMPHOMAS RECEIVING CART

EHA Library, Samuel Yamshon, 4208895

DURABLE CLINICAL BENEFITS WITH EXAGAMGLOGENE AUTOTEMCEL FOR PEDIATRIC PATIENTS (5-11 YEARS) WITH TRANSFUSION-DEPENDENT Β‑THALASSEMIA AND SICKLE CELL DISEASE WITH RECURRENT VASO-OCCLUSIVE CRISES

EHA Library, Franco Locatelli, 4208896

CAR T-CELL THERAPY FOR POST-TRANSPLANT LYMPHOPROLIFERATIVE DISEASE, A REAL-WORLD ANALYSIS ON BEHALF OF THE EBMT LYMPHOMA WORKING PARTY

EHA Library, Fabio Andreozzi, 4208897

REAL-WORLD USE OF RECOMBINANT HUMAN THROMBOPOIETIN (RHTPO) FOR SEVERE THROMBOCYTOPENIA AFTER CAR T-CELL THERAPY: PLATELET RECOVERY AND TRANSFUSION BURDEN STRATIFIED BY CAR-HEMATOTOX

EHA Library, Zixun Yan, 4208898

RELEVANT STUDY BETWEEN CYTOKINE LEVEL OF PATIENTS TREATED WITH CD7 CAR-T THERAPY AND GVHD AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION

EHA Library, Dongchu Wang, 4208899

TIME FROM CAR-T EVALUATION TO LEUKAPHERESIS IN B-CELL MALIGNANCIES: ASSOCIATION WITH INFUSION RATES AND OUTCOMES

EHA Library, Justin Desroches, 4208900

TENACITY-01 A GLOBAL STUDY OF CTD402, ALLOGENEIC ANTI-CD7 CAR T-CELL, IN RELAPSED OR REFRACTORY (R/R) T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA/LYMPHOBLASTIC LYMPHOMA (T-ALL/LBL)

EHA Library, Lori Muffly, 4208901

COMPARATIVE EFFICACY AND SAFETY OF BCMA-TARGETED VERSUS GPRC5D-TARGETED CAR-T CELL THERAPY IN RELAPSED/REFRACTORY MULTIPLE MYELOMA: A META-ANALYSIS

EHA Library, Yanling Li, 4208902

LATER CAR‑T INFUSIONS INCREASE CYTOKINE RELEASE SYNDROME (CRS): EVIDENCE FOR CIRCADIAN MODULATION OF IMMUNOTHERAPY-RELATED TOXICITY

EHA Library, Danielle DeCicco, 4208903

REAL WORLD EVALUATION OF ENTEROCOLITIS IN CILTA-CEL TREATED PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA

EHA Library, Doris Hansen, 4208904

IMMUNE EFFECTOR CELL–ASSOCIATED HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS FOLLOWING CAR T-CELL THERAPY: RESULTS OF A SINGLE-CENTER REAL-WORLD ANALYSIS

EHA Library, Inna Shaforostova, 4208905

INTERNATIONAL EXPERT CONSENSUS ON THE USE OF IMMUNOGLOBULIN REPLACEMENT THERAPY FOR SECONDARY IMMUNODEFICIENCY: A MODIFIED DELPHI STUDY

EHA Library, Michel Delforge, 4208906

OSIVELOTOR IMPROVES BIOMARKERS OF HEMOLYSIS, OXIDATIVE STRESS, AND INFLAMMATION IN PATIENTS WITH SICKLE CELL DISEASE IN A MULTICENTER PHASE 2/3 TRIAL

EHA Library, Santosh Saraf, 4208908

BIOLOGICAL DRIVERS AND FUNCTIONAL IMPACT OF MITOCHONDRIA-RETAINING RED BLOOD CELLS IN SICKLE CELL DISEASE

EHA Library, Alkmini Anastasiadi, 4208909

EARLY HYPERFILTRATION PREDICTS SUBSEQUENT RENAL DECLINE IN SICKLE CELL DISEASE: A LONGITUDINAL TRAJECTORY STUDY

EHA Library, Laura Corona, 4208910

SICKLE CELL DISEASE IN GERMANY - TRENDS IN EPIDEMIOLOGY, HEALTHCARE UTILIZATION AND DISEASE BURDEN FROM 2015 TO 2024: A CLAIMS DATA ANALYSIS

EHA Library, Nils Schulze, 4208911

THE HIDDEN BURDEN: FEMALE SEXUAL DYSFUNCTION AND PAIN CRISES IN SICKLE CELL DISEASE

EHA Library, Fernanda Bacarin, 4208912

DISSECTING THE MOLECULAR BASIS OF POTENT HBF INDUCTION BY BMS-986470: A MECHANISTIC STUDY OF ZBTB7A/WIZ DUAL DEGRADATION

EHA Library, Yan Kai, 4208913

BIVENTRICULAR REMODELING WITH PRESERVED MYOCARDIAL DEFORMATION IN PEDIATRIC SICKLE CELL DISEASE: SPECKLE-TRACKING ECHOCARDIOGRAPHY AND LONGITUDINAL ASSESSMENT

EHA Library, Miguel R. Abboud, 4208914

A METHOD FOR MONITORING RED CELL ENGRAFTMENT POST BONE MARROW TRANSPLANT FOR SICKLE CELL DISEASE

EHA Library, Azalea Khan, 4208915

LONGITUDINAL EFFECT OF HYDROXYUREA AND CHRONIC EXCHANGE TRANSFUSION THERAPIES ON ECHOCARDIOGRAPHIC PARAMETERS OF SICKLE CELL CARDIOMYOPATHY

EHA Library, Jackie Queen, 4208916

CO-DESIGNING A CULTURALLY-TAILORED SELF-MANAGEMENT TOOLBOX FOR UNIVERSITY STUDENTS WITH SICKLE CELL DISEASE IN SAUDI ARABIA: INTEGRATED MRC 2021 FRAMEWORK AND PERSON-BASED APPROACH

EHA Library, Reham Almabadi, 4208917

SHIFTING ATTRIBUTION OF SICKLE CELL DISEASE ON US DEATH CERTIFICATES: A NATIONAL MULTIPLE CAUSE-OF-DEATH ANALYSIS, 2003–2024

EHA Library, Hala Soomro, 4208918

DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED STUDY OF CROVALIMAB FOR THE TREATMENT OF ACUTE VASO-OCCLUSIVE EPISODES IN SICKLE CELL DISEASE: RESULTS OF THE PHASE 1B CROSSWALK-A TRIAL

EHA Library, Satheesh Chonat, 4208919

CHANGING EPIDEMIOLOGY OF SICKLE CELL DISORDERS: GBD 2023 ANALYSIS OF INCIDENCE TRENDS TO 2023, REGIONAL DISPARITIES IN EUROPE, AND IMPLICATIONS FOR GENE THERAPY ACCESS

EHA Library, Tapan Giri, 4208921